Nazwa produktu: |
4-[2-[(2R,3R)-3-(2,4-difluorofenylo)-3-hydroksy-4-(1,2,4-triazol-1-ylo)b utan-2-yl]-1,3-tiazol-4-ylo]benzonitryl |
Synonimy |
Ravukonazol [INN]; 207147 BMS; ER 30346; Rawukonazol; p-(2-((alfaR,betaR)-2,4-difluoro-beta-hydroksy-alfa-metylo-beta-(1H-1,2,4-triazol-1-ylometylo)fenetylo)-4-tiazolylo)benzonitryl; benzonitryl, 4-(2-((1R,2R)-2-(2,4-difluorofenylo)-2-hydroksy-1-metylo-3-(1H-1,2,4-triazol-1-ylo)propylo)-4-tiazolylo)-; 4-{2-[(1R,2R)-2-(2,4-difluorofenylo)-2-hydroksy-1-metylo-3-(1H-1,2,4-triazol-1-ylo)propylo]-1,3-tiazol-4-ylo}benzonitryl |
Angielska nazwa |
4-[2-[(2R,3R)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)b utan-2-yl]-1,3-thiazol-4-yl]benzonitrile;Ravuconazole [INN]; BMS 207147; ER 30346; Ravuconazole; p-(2-((alphaR,betaR)-2,4-Difluoro-beta-hydroxy-alpha-methyl-beta-(1H-1,2,4-triazol-1-ylmethyl)phenethyl)-4-thiazolyl)benzonitrile; Benzonitrile, 4-(2-((1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl)-4-thiazolyl)-; 4-{2-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-1,3-thiazol-4-yl}benzonitrile |
MF |
C22H17F2N5OS |
Masie cząsteczkowej |
437.4651 |
InChI |
InChI=1/C22H17F2N5OS/c1-14(21-28-20(10-31-21)16-4-2-15(9-25)3-5-16)22(30,11-29-13-26-12-27-29)18-7-6-17(23)8-19(18)24/h2-8,10,12-14,30H,11H2,1H3/t14-,22+/m0/s1 |
Nr CAS |
182760-06-1 |
Struktury molekularnej |
|
Gęstość |
1.38g/cm3 |
Temperatura wrzenia |
674.9°C at 760 mmHg |
Współczynnik załamania |
1.665 |
Temperatura zapłonu |
362°C |
Ciśnienie pary |
3.89E-19mmHg at 25°C |
Symbole zagrożenia |
|
Kody ryzyka |
|
Bezpieczeństwo opis |
|
|